Dolby Family Ventures

Talkspace is an online mental health care platform that provides research-backed therapy and psychiatric services covered by insurance, allowing users to connect with licensed therapists and psychiatrists through text, audio, or video.

Digital HealthHealthtechMental Health

Oren Frank(Founder)inJon Cohen, M.D.in

Co-investorsCompoundHDS CapitalQumra CapitalRunway Venture PartnersVillage GlobalAlpine Ventures+13 more

AccuKnox provides automated adversarial testing for large language models, machine learning models, and cloud AI infrastructure to detect security vulnerabilities including prompt injection, jailbreaks, hallucinations, and misconfigurations.

AI & Machine LearningCloud ComputingCybersecurityEnterprise Software

Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersMDSV CAPITALOutliers VCZ5 Capital

AccuKnox provides a Zero Trust security platform covering AI, API, application, cloud, Kubernetes, data, and supply chain security, using eBPF and LSM-based runtime protection for enterprise and public sector organizations.

AI & Machine LearningCloud ComputingCybersecurity

Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersSparq Capital (SFO)

Kuprion develops ActiveCopper materials and printable conductive inks used to manage heat in high-power, high-temperature electronic systems, serving electronics engineers and manufacturers across industries including semiconductor packaging, electric vehicles, and 5G communications.

HardwareNew MaterialsSemiconductorsSan Jose, US

Dr. Alfred Zinn(Founder)

Co-investorsAlsop Louie Partners

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

Nicholas Flanders(Founder & CEO)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

Co-investorsBreakout VenturesDCVC (Data Collective)Fifth WallAdvantage Partners Inc.Aera VCCantos Ventures+15 more

Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)

BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in

Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesEMV Capital+3 more

Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits.

BiotechDeep TechHealthtechKensington, US

Joseph Bondy-Denomy(Director)David Rabuka(Executive Officer, Director, Promoter)Karen Boezi(Director)

Co-investorsBerkeley Catalyst

Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.

Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials

Pavle Jeremic(Founder & CEO)Jay Zaveri(Co-Founder & President)

Co-investors4DX VenturesAbstract VenturesArtis VenturesBlue Bear VenturesBoxGroupCalm Ventures+7 more

all.health offers an Integrated Continuous Management (ICM) platform combining a clinical-grade wearable with an FDA-recognized system that collects 24/7 vitals and biometrics, screens for disease risk, and links patients to their care teams.

AI & Machine LearningDigital HealthHealthtech

Co-investorsMindset VentureSignalFireMorpheus VenturesReinvent Capital

Co-investorsCentral Texas Angel Network

A biotechnology company developing new therapies for patients with high unmet medical needs.

Biotech

Co-investorsSofinnova Ventures

Atmosic designs ultra-low-power wireless connectivity and compute chips for connected devices, aiming to extend battery life or enable battery-free operation.

HardwareIoTSemiconductorsCampbell, US

David Su(Founder)Masoud Zargari(Founder)

Co-investorsClear Ventures

Denver, US

Co-investorsMatchstick VenturesPure VenturesTechstarsUrania VenturesCantos VenturesStout Street Capital

Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Izhar Wallach(Executive Officer, Director)inAbraham Heifets(Executive Officer, Director, Promoter)Yan Zhao(Executive Officer)Stephen Worland(Executive Officer, Director)

BoardRobert Mittendorff(Director)inAdam Seabrook(Director)in

Co-investorsAurum Venture PartnersB Capital GroupCerity Partners VenturesCreative Destruction Lab (CDL)Draper AssociatesThreshold Ventures+5 more

Authentic Vision provides mobile product authentication technology using a copy-proof Holographic Fingerprint and computer vision algorithms that let anyone verify products with a smartphone, along with real-time scan geolocation, analytics, and Digital Product Passport features.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsJoint Effects

Co-investorsBold Capital PartnersCompoundDeep InsightFlucas VenturesUpfront VenturesWhat If Ventures

Cajal Therapeutics develops small molecule and RNA medicines aimed at restoring iron homeostasis to treat serious diseases, including anemias of inflammation, neurodegenerative diseases, and other iron-related disorders.

BiotechDigital Health

Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor.

Deep TechDigital HealthHealthtechMedical DevicesSilicon Valley, US

Kate Rosenbluth, PhD(President & Chief Innovation Officer)Kate Rosenbluth(Founder)inDeanna Harshbarger(Chief Executive Officer)

Co-investorsAscension VenturesGlobal BrainGV (Google Ventures)Lightstone VenturesOSF VenturesTriventures+1 more

California Catalysts develops advanced materials and catalysts for hydrogen electrolysis using AI-driven discovery methods.

AI & Machine LearningCleantechEnergyNew MaterialsLos Angeles, US

Jim DiSanto(Co-founder, Board Director, Executive Consultant)

BoardNathan Lewis(Chief Scientific Advisor)

Co-investorsAcario InnovationMOL SwitchTSVCVoLo Earth VenturesMotus Ventures, Llc

Canaery (now General Sense) is developing scent-detection technology aimed at extending capabilities beyond the limits of human olfactory perception.

Deep TechHardware

Co-investors15th RockGood News VenturesBreakout VenturesKdT Ventures

Cato Digital provides bare metal cloud infrastructure using redeployed high-performance servers from Meta and NVIDIA, targeting AI, machine learning, compute, and storage workloads.

AI & Machine LearningCleantechCloud Computing

Co-investorsCowles Ventures

Cerevance is a clinical-stage drug discovery and development company developing non-dopaminergic, orally-delivered therapies for brain and central nervous system disorders, including Parkinson's disease, schizophrenia, Alzheimer's disease, and ALS.

BiotechDeep TechHealthtech

Craig Thompson(Chief Executive Officer)Sagar Vaidya(Chief Medical Officer)Carrie Ann Cook(Chief Business Officer)

Co-investorsForesite CapitalGV (Google Ventures)Dementia Discovery FundSV Life SciencesDementia DiscoveryLightstone Ventures+2 more

Cognition Therapeutics is a clinical-stage biotechnology company developing zervimesine (CT1812), an investigational once-daily oral small-molecule therapy designed to protect brain synapses by blocking toxic protein oligomers.

BiotechHealthtechPittsburgh, US

Susan Catalano(Executive Officer, Director)Harold Safferstein(Executive Officer, Director)

BoardNada Jain(Director)Franz Hefti(Director)Robert Gailus(Director)Mark Breedlove(Director)

Co-investors3E Bioventures CapitalAtlanta Technology AngelsHouston Angel NetworkiNetworks

Cognitive Space develops AI-driven automation software for satellite operations, enabling constellation operators to scale while meeting operational requirements.

AI & Machine LearningDefense TechSaaSSpace TechHouston, US

Marc Bell(Co-Founder and CEO)Guy de Carufel(CEO & Founder)Dax Garner(CTO)Jeff Edwards(VP of Engineering)Hanna Steplewska(Executive Officer, Director)Jennifer Roberts(Director)in

Co-investorsCapital InnovatorsCreative Destruction Lab (CDL)Draper AssociatesGlasswing VenturesGrit VenturesGutbrain Ventures+7 more

Co-investorsPfizer Venture Investments

CQuesta develops agricultural biotechnology validated in laboratory, greenhouse, and field trials, with results including higher crop yields, improved stress resilience, and more efficient nutrient use.

AgTechBiotechClimate Tech

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesPsyMed VenturesRA Capital+3 more

DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.

Deep TechHardwareNew MaterialsSunnyvale, US

Jonathan Waldern(Director)Christopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)

BoardJim Whims(Director)

Co-investorsAlsop Louie PartnersBold Capital PartnersDiamond Edge VenturesNautilus Ventures Management Company (Us), LlcSony Ventures CorporationMITSUBISHI CHEMICAL

Co-investorsGreen Park & Golf VenturesThe Perkins Fund

Eargo was a hearing aid company that provided high-quality hearing aids and related care services.

HealthtechMedical DevicesMountain View, US

Raphael Michel(Executive Officer, Director)Christian Gormsen(Executive Officer, Director)William Brownie(Executive Officer)Peter Tuxen Bisgaard(Director)

BoardDavid Wu(Director)inJosh Makower(Director)

Co-investorsBirchmere VenturesLongitude CapitalMaveronNew Enterprise Associates (NEA)Montage VenturesRed Sea Ventures

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Anthony DePasqua(Executive Officer, Director)inTony DePasqua(President & CEO)Kevin Kalish(COO)Marcie Glicksman(VP Biology)William Gormley(CMO)Jason Camm(Director)

Co-investors20/20 HealthCare Partners LLCFlucas VenturesTachyon VenturesVU Venture Partners

Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.

AI & Machine LearningBiotechMedical DevicesNew York, US

Maria Pineda, PhD(CEO & Co-founder)Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Executive Officer, Director, Promoter)Maria Luisa Pineda(Executive Officer, Director, Promoter)Maria Luisa Pineda, PhD.(Founder)in

Co-investorsDynamk CapitalHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital

Esper provides hyperspectral satellite imagery and geochemical analysis to identify critical minerals and alteration zones for mining exploration and environmental monitoring.

AgTechDeep TechSpace TechPatterson Lakes, AU

JoeyShoaib Iqbal(Chief Executive Officer)Przemyslaw Lorenczak(Chief Technology Officer)

Co-investorsCroc PitchNZVCTechstars

Genemod offers a lab management platform that combines electronic lab notebook (ELN), LIMS, inventory, and equipment tracking in one data model, with AI agents that plan experiments, execute protocols across connected systems, and generate audit-ready records.

AI & Machine LearningBiotechHealthtechSaaSEdmonds, US

Jacob Lee(Executive Officer, Director, Promoter)Zachary Gut(Director)Michael Gregoire(Director)Jin Choe(Director, Promoter)Anil Arora(Executive Officer)

BoardNeil Sequeira(Director)in

Co-investorsAmino CapitalDefy Partnersfutureland venturesLDV Partners

Vacaville, US

Kirk Hawkins(Executive Officer, Director)Rich Bridge(Executive Officer)Thomas Wieners(Executive Officer)Katherine DeHoff(Executive Officer)

BoardLiu Dan(Director)Du Yang(Director)

Co-investorsSeraph Group

Kebotix uses artificial intelligence, machine learning, and laboratory automation to discover and develop new materials and molecules.

AI & Machine LearningDeep TechNew MaterialsCambridge, US

Dennis Sheberla(Executive Officer)Semion Saykin(Executive Officer)Alan Aspuru-Guzik(Executive Officer)inAshish Kulkarni(Executive Officer, Director)

BoardTong Hui(Director)Andrew Krowne(Director)in

Co-investorsArcTern VenturesBantam GroupFlybridge Capital PartnersOne Way VenturesPropagator VenturesSafar Partners+3 more

LeoLabs operates a network of ground-based radars and an AI-enabled cloud platform that tracks and maps objects and activity in low Earth orbit.

AI & Machine LearningDefense TechSpace Tech

Daniel Ceperley(Founder)in

Co-investorsHemisphere Ventures LLCMDSV CAPITALNZ Growth Capital PartnersSeraphim SpaceSpace CapitalSparq Capital (SFO)+2 more

Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease.

BiotechLongevityMedical Devices

Dr. Gill(Chief Scientific Officer)

Co-investorsEpidarex Capital

Lightform made hardware and software for projection mapping, using structured light scanning to align projected augmented-reality visuals onto physical forms for art, experiences, and signage.

AI & Machine LearningDeep TechHardware

Co-investorsComet LabsCrunchFundPresence CapitalTuesday Capital

Magnefy develops hybrid magnetic sensing and signal-processing hardware combined with AI/ML for monitoring critical infrastructure in harsh, real-world environments.

Deep TechHardwareIoTPalo Alto, US

Joseph Kao(CEO & Co-Founder)inDerrick Du(Founding Product Manager)inAsma Mahar(Head of Hardware - Sensors & Signal Processing)in

Co-investorsSunna VenturesDangerous Ventures

Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.

BiotechDigital HealthMedical DevicesMental HealthBurlingame, US

Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)Vikram Lamba(Executive Officer)

BoardXingjuan Chao(Director)Andrew Firlik(Director)inHeath Lukatch(Director)

Co-investorsJAZZ Venture PartnersRed Tree Venture

Medcrypt provides cybersecurity products and strategic consulting to medical device manufacturers to ensure their devices are secure by design and meet FDA regulatory requirements.

CybersecurityHealthtechMedical Devices

Mike Kijewski(Founder)in

Co-investorsEniac VenturesIntuitive VenturesSection 32Y Combinator

BiotechKingston, US

Robert B. Nelson(Executive Officer, Director)Frank S. Menniti(Executive Officer, Director)Stevin Zorn(Executive Officer, Director)Isaac Stoner(CEO)

BoardRichard G. Horan(Director)Reetika Bhardwaj(Director)

Co-investorsPfizer Venture InvestmentsPfizer VenturesSlater Technology Fund

Mojo Vision develops micro-LED technology, positioning it as a platform for AI infrastructure and next-generation displays.

Deep TechHardwareSemiconductors

Nikhil Balram(Chief Executive Officer)Mike Wiemer(Chief Technology Officer)G. Aaron James(General Counsel)

BoardSteve Jurvetson(Founder)in

Co-investorsARC Angel FundArgonautic VenturesBold Capital PartnersDisney AcceleratorFlucas VenturesFusion+13 more

Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)

Co-investorsTwo Bear Capital

Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD).

BiotechDigital Health

Co-investorsElevate Ventures

Moove.ai applies machine learning to real-time connected vehicle data to assess transportation risk and build mitigation tools focused on road safety and efficiency.

AI & Machine LearningData & InfrastructureMobility & Transportation

Co-investorsCortado VenturesMotivate Venture CapitalUber

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)

BoardJacob Robinson(Co-founder & CEO)in

Co-investorsArboretum VenturesPsyMed VenturesTMC Venture FundCapital FactoryDivergent CapitalKdT Ventures+2 more

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.

BiotechDeep TechHealthtechMedical DevicesSomerville, US

MJ Antonini(Founder, CEO)Nicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)

Co-investorsFuture VenturesGreyMatterVanedge CapitalVanedge Capital Limited PartnershipLIONHEART VENTURES

NeuroTherapia develops oral, small molecule therapeutics that inhibit microglia cells to target neuroinflammation in central nervous system (CNS) diseases such as Alzheimer's disease.

BiotechHealthtech

NextSense makes Smartbuds, EEG earbuds with dry-contact sensors that measure brain activity and adapt audio in real time to increase deep sleep, meditation, and focus.

Digital HealthHardwareWellness & FitnessMountain View, US

Jonathan Berent(Founder)

Co-investorsAscension Ventures

Niantic Labs develops mobile games and apps that encourage outdoor exploration and real-world community engagement through location-based gaming experiences.

ConsumerGamingSan Francisco, US

John Hanke(Executive Officer, Director)

BoardKenji Okubo(Director)

Co-investorsAir Street CapitalAloft VCBonfire VenturesBreyer CapitalCapitalGCauseway Partners+12 more

Niantic Spatial builds real-world foundation models for physical AI, offering capabilities to reconstruct geometrically accurate 3D digital twins, localize devices without relying on GPS via a Visual Positioning System, and interpret 3D environments.

AI & Machine LearningDeep TechRoboticsSan Francisco, US

John Hanke(Executive Officer, Director)Katherine Richard-Dodson(Executive Officer)Christopher Chow(Executive Officer)Thomas Gewecke(Executive Officer)

BoardGilman Louie(Director)inMegan Quinn(Director)

Co-investorsAlsop Louie PartnersJavelin Venture PartnersScopely

OKAPI:Orbits provides AI-based Space Traffic Management (STM) and Space Situational Awareness (SSA) software platforms along with consulting services for satellite operators.

AI & Machine LearningSaaSSpace TechBraunschweig, DE

Kristina Nikolaus(Founder)in

Co-investorsAmadeus Capital PartnersMatterwave VenturesMunich Re Ventures

Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.

BiotechDeep TechHealthtechMedical DevicesAustin, US

Matt Angle(Founder and CEO)in

Co-investors15th RockAlpha EdisonAnthropy PartnersCapital FactoryCoastCapFrontier Path VC+14 more

BiotechRaleigh, US

Frank M. Longo(Director)Anne C. Longo(Executive Officer)

BoardRobert Sims(Director)

Phase Four developed in-space electric and multi-mode satellite propulsion; its technology assets were sold in 2025.

Hawthorne, US

STEPHEN KISER(Executive Officer, Director)inSimon Halpern(Executive Officer, Director)

BoardStewart Alsop(Director)inTHOMAS J.A. LAVIN(Director)JAMES BRIDENSTINE(Director)

Co-investorsAlsop Louie PartnersIndustrious VenturesNew Science VenturesVeteran Ventures Capital

Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells.

BiotechDeep TechMedical DevicesWatertown, US

Dmitrij Hristodorov(Director)Christopher Loose(Executive Officer, Director)Sanjay Magavi(Executive Officer)Marc-Olivier Turgeon(Director)

BoardAleks Radovic-Moreno(Director)inDan Janney(Director)

Co-investorsAlta PartnersLongwood FundMission BiocapitalForbionService Provider Capital